Explore more publications!

New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on April 15, 2026

Synametrics Technologies releases a new version of  Syncrify, Version 6.2 (Build 1178).
Herb Haus Celebrates Strong Community Reception and Introduces the Team Behind the Vision
Achieve Wellness & Recovery boosts access in Atlantic, Camden & Monmouth Counties for its 2026 healthcare initiative.
Geared Power BioTech accepted into the FDA’s Safer Technologies Program for its BioGuard UVC™ device
Inteleos Foundation تعلن عن جائزة MedMissions لعام 2026 لتعزيز نطاق الوصول إلى خدمات التصوير بالموجات فوق الصوتية لصحة الأم في خمس دول
Inteleos Foundation annonce les lauréats du Prix MedMissions 2026 pour renforcer l’accès à l’échographie maternelle dans cinq nations
 What if you could reboot sick cells?
Cerene® by Channel Medsystems Partners with Hey Girl! Fund to Support Menstrual Education at Caregivers & Girlies Brunch on Saturday, April 18
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
Walking Yoga App: How Combining Walking and Yoga Accelerates Weight Loss
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform
Sienna Announces April Dividend
Annual General Meeting of Kuros Biosciences approves all resolutions
NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions